We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Track real-time Director Deals activity on the London Stock Exchange (LSE)
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| -14.50 | -1.00% | 1,435.00 | 1,433.50 | 1,434.00 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 1,441.50 | 1,424.00 | 1,432.50 | 5,139,881 | 16:35:22 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 31.38B | 2.58B | 0.6287 | 22.81 | 59.37B |
| Date | Time | Source | Headline |
|---|---|---|---|
| 19/6/2025 | 07:00 | UK RNS | GSK PLC Transaction in Own Shares |
| 18/6/2025 | 07:00 | UK RNS | GSK PLC Transaction in Own Shares |
| 17/6/2025 | 12:36 | ALNC |  DIRECTOR DEALINGS: New B&M CEO Tjeerd Jegen buys GBP500,000 in shares |
| 17/6/2025 | 07:00 | UK RNS | GSK PLC Transaction in Own Shares |
| 16/6/2025 | 07:00 | UK RNS | GSK PLC Transaction in Own Shares |
| 13/6/2025 | 15:30 | UK RNS | GSK PLC Director/PDMR Shareholding |
| 13/6/2025 | 08:14 | ALNC | GSK's RSV drug Arexvy accepted for regulatory review in Europe |
| 13/6/2025 | 07:00 | UK RNS | GSK PLC Transaction in Own Shares |
| 13/6/2025 | 07:00 | UK RNS | GSK PLC GSK submits Arexvy for adults 18+ with EMA |
| 12/6/2025 | 13:28 | ALNC | DIRECTOR DEALINGS: Cerillion CEO seeks to sell GBP20 million in shares |
1 Year Gsk Chart |
Intraday Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
